Quantbot Technologies LP Aclaris Therapeutics, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $61,509 - $156,165	8,700 New	8,700 $70,000
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $9,386 - $14,144	-765 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.38 - $18.8 $10,235 - $14,382	765 New	765 $13,000
Q1 2021 May 14, 2021	SELL	$5.86 - $27.73 $1,172 - $5,546	-200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.65 - $7.61 $530 - $1,522	200 New	200 $1,000
Q1 2018 May 11, 2018	SELL	$17.08 - $25.64 $123,044 - $184,710	-7,204 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$21.47 - $27.8 $71,924 - $93,130	3,350 Added 86.92%	7,204 $177,000
Q3 2017 Nov 07, 2017	BUY	$23.02 - $28.8 $88,719 - $110,995	3,854	3,854 $99,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.